These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
730 related items for PubMed ID: 7539044
21. Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitro. Schmidt C, Burrows SR, Moss DJ, Sculley TB, Misko IS. Scand J Immunol; 1991 Apr; 33(4):411-20. PubMed ID: 1708166 [Abstract] [Full Text] [Related]
22. Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. Shi Y, Smith KD, Kurilla MG, Lutz CT. J Immunol; 1997 Aug 15; 159(4):1844-52. PubMed ID: 9257848 [Abstract] [Full Text] [Related]
23. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Torsteinsdottir S, Masucci MG, Ehlin-Henriksson B, Brautbar C, Ben Bassat H, Klein G, Klein E. Proc Natl Acad Sci U S A; 1986 Aug 15; 83(15):5620-4. PubMed ID: 3016710 [Abstract] [Full Text] [Related]
24. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB. J Virol; 1993 Dec 15; 67(12):7428-35. PubMed ID: 7693972 [Abstract] [Full Text] [Related]
26. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G. Proc Natl Acad Sci U S A; 1987 Jul 15; 84(13):4567-71. PubMed ID: 3037521 [Abstract] [Full Text] [Related]
27. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2. Khanna R, Burrows SR, Suhrbier A, Jacob CA, Griffin H, Misko IS, Sculley TB, Rowe M, Rickinson AB, Moss DJ. J Immunol; 1993 Jun 01; 150(11):5154-62. PubMed ID: 7684421 [Abstract] [Full Text] [Related]
29. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). Burrows SR, Sculley TB, Misko IS, Schmidt C, Moss DJ. J Exp Med; 1990 Jan 01; 171(1):345-9. PubMed ID: 1688611 [Abstract] [Full Text] [Related]
30. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity. Torsteinsdottir S, Cuomo L, Klein E, Masucci MG. Cell Immunol; 1991 Oct 15; 137(2):501-13. PubMed ID: 1654213 [Abstract] [Full Text] [Related]
31. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones. Livingston PG, Kurane I, Ennis FA. J Virol Methods; 1997 Aug 15; 67(1):77-84. PubMed ID: 9274820 [Abstract] [Full Text] [Related]
32. Application of the ELISPOT assay to the characterization of CD8(+) responses to Epstein-Barr virus antigens. Yang J, Lemas VM, Flinn IW, Krone C, Ambinder RF. Blood; 2000 Jan 01; 95(1):241-8. PubMed ID: 10607708 [Abstract] [Full Text] [Related]
33. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG. J Virol; 1993 Mar 01; 67(3):1572-8. PubMed ID: 7679748 [Abstract] [Full Text] [Related]
34. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen. Hank JA, Sondel PM. Hum Immunol; 1984 Apr 01; 9(4):211-9. PubMed ID: 6201468 [Abstract] [Full Text] [Related]
35. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG. Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426 [Abstract] [Full Text] [Related]
36. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus. Subklewe M, Chahroudi A, Schmaljohn A, Kurilla MG, Bhardwaj N, Steinman RM. Blood; 1999 Aug 15; 94(4):1372-81. PubMed ID: 10438725 [Abstract] [Full Text] [Related]
37. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis. Enssle KH, Fleischer B. Clin Exp Immunol; 1990 Mar 15; 79(3):409-15. PubMed ID: 1690617 [Abstract] [Full Text] [Related]
38. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes. Pepperl S, Benninger-Döring G, Modrow S, Wolf H, Jilg W. J Virol; 1998 Nov 15; 72(11):8644-9. PubMed ID: 9765404 [Abstract] [Full Text] [Related]
39. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB. J Exp Med; 1997 May 05; 185(9):1605-17. PubMed ID: 9151898 [Abstract] [Full Text] [Related]
40. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. Tomkinson BE, Maziarz R, Sullivan JL. J Immunol; 1989 Jul 15; 143(2):660-70. PubMed ID: 2472449 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]